News

Purple Day has been held annually around the world on March 26: tens of thousands of people celebrate this day by wearing something purple and taking part in initiatives on epilepsy.

To mark International Women’s Day, Angelini Pharma is once again at the side of the IBE, to support “Women and Epilepsy”, an awareness project to eliminate the stigma against women with epilepsy.

The terrible earthquake that has claimed tens of thousands of lives in Turkey and Syria is a tragedy that cannot leave us indifferent. We at Angelini Pharma feel the need and responsibility to act concretely.

Today, on the occasion of the International Epilepsy Day, Angelini Pharma amplifies IBE’s raising awareness commitment by sharing videos of steps taken and donated to the campaign.

His arrival ushers us into a new chapter in our history, into a new synthesis of tradition and specialised innovation, at a crucial time for health.

The World Cancer Day (WCD) supports cancer awareness, education, and action to promote treatment, prevention, and care for all patients.

Telemedicine will reduce healthcare waiting lists and “electronic” medicines are already as effective as real ones.

Thanks to the involvement of everyone in the company, together with colleagues from the Angelini Industries Group, the goal will be to total one million steps altogether, counting them via a virtual pedometer.

Angelini Pharma, for the fourth consecutive year, is Top Employer Europe with local certifications in Italy, Spain, Portugal, Poland, Turkey, Germany and Romania.

The Committee for Medicinal Products for Human Use (CHMP) has recommended approval to the extension of the existing indication of Xydalba (dalbavancin) to include the pediatric population.